Spanish Red Biotech Pipeline

Merck KGaA

Tepotinib MET kinase inhibitor

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer with MET Exon 14 Skipping Alterations or MET Amplification
Phase: 2Phase II in Spain, 1Phase I